Clinically Significant Prostate Cancers Found Despite Low PSA
Recent study raises questions about the use of MRI as a first-line screening test. Even men with a low PSA level can harbor clinically significantly prostate cancer.
Stay updated with breaking news from European Randomized Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Recent study raises questions about the use of MRI as a first-line screening test. Even men with a low PSA level can harbor clinically significantly prostate cancer.
Recent study raises questions about the use of MRI as a first-line screening test. Even men with a low PSA level can harbor clinically significantly prostate cancer.
Recent study raises questions about the use of MRI as a first-line screening test. Even men with a low PSA level can harbor clinically significantly prostate cancer.
This preliminary descriptive report compares the rates of detecting high- and low-grade prostate cancer in men invited for prostate cancer screening vs
The introduction of prostate-specific antigen (PSA)–based screening for prostate cancer in the early 1990s was followed by a nearly 2-decade long decline